Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

US, UK equities upgraded at UBS, Europe downgraded

Investing.com — UBS upgraded US and UK stock markets, while downgrading Europe, the firm revealed in a Tuesday note.

The bank lifted UK equities to Overweight, a move based on the sector-adjusted price-to-earnings (P/E) ratio relative to the MSCI AC World, which is currently at a 25% discount.

UBS notes that UK markets are defensive in nature and could benefit from a stronger dollar. The firm’s above-consensus GDP growth forecast for the UK, coupled with a lower-than-consensus interest rates projection, also supports its positive outlook.

In addition, the market also has “less ‘Trump’ risk on our scorecard than any major non-US Market,” UBS strategists led by Andrew Garthwaite said.

Sector-wise, the investment bank highlights domestic sectors such as retailing, UK banks, homebuilders, and brick manufacturers as particularly attractive, as well as “many cheap stocks versus peers and have underperformed their peers.” These include Relx PLC ADR (NYSE:RELX), Experian PLC (LON:EXPN), Smith & Nephew SNATS Inc (NYSE:SNN), and Imperial Brands PLC (LON:IMB), among others.

In the case of US equities, UBS points to a number of reasons for the upgrade. The US is seen as a favorable destination when global growth slows, given its low operational leverage, flexible labor market, and the Federal Reserve’s dual mandate.

The firm also acknowledges potential policy changes that could benefit the US under the Trump administration. However, UBS stops short of an Overweight rating, noting that a lot of the ‘Trump hope’ is already priced in, and that valuations are at new highs relative to global markets.

Further concerns about the US include a forecasted slowdown in GDP growth and the implications of a strong dollar on earnings revisions.

Despite downgrading Europe to Benchmark status, UBS advises against underweighting European equities.

The downgrade is attributed to poor relative earnings and economic momentum. However, UBS points out that the sector-adjusted P/E ratio for Europe compared to the US is at a significant discount, and there are expectations for the gap in GDP growth between the US and Europe to narrow.

The European Central Bank’s anticipated rate cuts and the potential impact of a weaker Euro on earnings growth are also mentioned as possible catalysts. Furthermore, UBS believes that Europe’s fiscal position “is not reflected at all in valuations.”

The firm remains cautious on China but notes potential near-term improvements in Chinese lead indicators.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com